Tritiodestannylation. Synthesis of a Specifically Labelled [3H]Tamoxifen
Authors:
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Synthetic Communications
- Vol. 11 (4) , 281-286
Abstract
The recent development of nonsteroidal antiestrogens has increased the prospects for the management of metastatic breast cancer, the most prevalent malignancy among North American and European women. Of these, clinical results have demonstrated tamoxifen (1) to be at least as effective as conventional hormonal treatment while manifesting much reduced side effects.2 As part of a program designed to evaluate inhibitors of aromatization for therapy of breast cancer, we required a tritiated derivative of tamoxifen for pharmacodynamic and radioimmunqassay studies.Keywords
This publication has 6 references indexed in Scilit:
- Iododestannylation. Position-specific synthesis of iodotamoxifenJournal of Organometallic Chemistry, 1980
- Iodine-125-labelled Tamoxifen is Differentially Cytoxic to Cells Containing Oestrogen ReceptorsInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1980
- Heteroatom‐Facilitated Lithiations1979
- Antiestrogens: Mechanism of Action and Effects in Breast Cancer1978
- Infrared spectra of trifluoroacetic acid and trifluoroacetic anhydrideSpectrochimica Acta Part A: Molecular Spectroscopy, 1971
- Preparation and Identification of cis and trans Isomers of a Substituted TriarylethyleneNature, 1966